nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproheptadine—migraine—Prednisone—chronic obstructive pulmonary disease	0.426	1	CpDpCtD
Cyproheptadine—HTR2A—chronic obstructive pulmonary disease	0.243	1	CbGaD
Cyproheptadine—CHRM3—Tiotropium—chronic obstructive pulmonary disease	0.0765	0.374	CbGbCtD
Cyproheptadine—CHRM1—Tiotropium—chronic obstructive pulmonary disease	0.0665	0.326	CbGbCtD
Cyproheptadine—CHRM2—Tiotropium—chronic obstructive pulmonary disease	0.0613	0.3	CbGbCtD
Cyproheptadine—HTR2A—phrenic nerve—chronic obstructive pulmonary disease	0.00552	0.389	CbGeAlD
Cyproheptadine—HTR2A—pulmonary artery—chronic obstructive pulmonary disease	0.002	0.141	CbGeAlD
Cyproheptadine—Epigastric distress—Salbutamol—chronic obstructive pulmonary disease	0.00196	0.0265	CcSEcCtD
Cyproheptadine—Extrasystoles—Aminophylline—chronic obstructive pulmonary disease	0.00126	0.017	CcSEcCtD
Cyproheptadine—Ketotifen—PDE4A—chronic obstructive pulmonary disease	0.001	0.288	CrCbGaD
Cyproheptadine—Extrasystoles—Formoterol—chronic obstructive pulmonary disease	0.000958	0.0129	CcSEcCtD
Cyproheptadine—Extrasystoles—Arformoterol—chronic obstructive pulmonary disease	0.000958	0.0129	CcSEcCtD
Cyproheptadine—Extrasystoles—Salbutamol—chronic obstructive pulmonary disease	0.000904	0.0122	CcSEcCtD
Cyproheptadine—Chest discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00086	0.0116	CcSEcCtD
Cyproheptadine—Wheezing—Montelukast—chronic obstructive pulmonary disease	0.000766	0.0103	CcSEcCtD
Cyproheptadine—Wheezing—Salbutamol—chronic obstructive pulmonary disease	0.000739	0.00997	CcSEcCtD
Cyproheptadine—Irritability—Aminophylline—chronic obstructive pulmonary disease	0.000733	0.0099	CcSEcCtD
Cyproheptadine—Urinary retention—Aminophylline—chronic obstructive pulmonary disease	0.000731	0.00986	CcSEcCtD
Cyproheptadine—Urinary retention—Tiotropium—chronic obstructive pulmonary disease	0.000689	0.0093	CcSEcCtD
Cyproheptadine—Tension—Roflumilast—chronic obstructive pulmonary disease	0.000681	0.00919	CcSEcCtD
Cyproheptadine—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.000674	0.00909	CcSEcCtD
Cyproheptadine—Euphoric mood—Salbutamol—chronic obstructive pulmonary disease	0.000654	0.00882	CcSEcCtD
Cyproheptadine—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.00065	0.00877	CcSEcCtD
Cyproheptadine—Nasal congestion—Formoterol—chronic obstructive pulmonary disease	0.000642	0.00866	CcSEcCtD
Cyproheptadine—Nasal congestion—Arformoterol—chronic obstructive pulmonary disease	0.000642	0.00866	CcSEcCtD
Cyproheptadine—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.000624	0.00841	CcSEcCtD
Cyproheptadine—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.000613	0.00827	CcSEcCtD
Cyproheptadine—Nasal congestion—Salbutamol—chronic obstructive pulmonary disease	0.000606	0.00818	CcSEcCtD
Cyproheptadine—Increased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000588	0.00793	CcSEcCtD
Cyproheptadine—Neuritis—Prednisolone—chronic obstructive pulmonary disease	0.000584	0.00789	CcSEcCtD
Cyproheptadine—SLC6A2—respiratory system—chronic obstructive pulmonary disease	0.000561	0.0395	CbGeAlD
Cyproheptadine—Irritability—Montelukast—chronic obstructive pulmonary disease	0.000547	0.00738	CcSEcCtD
Cyproheptadine—Irritability—Salbutamol—chronic obstructive pulmonary disease	0.000527	0.00711	CcSEcCtD
Cyproheptadine—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.000512	0.00691	CcSEcCtD
Cyproheptadine—DRD2—respiratory system—chronic obstructive pulmonary disease	0.000511	0.036	CbGeAlD
Cyproheptadine—HTR2B—smooth muscle tissue—chronic obstructive pulmonary disease	0.000508	0.0358	CbGeAlD
Cyproheptadine—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.000499	0.00673	CcSEcCtD
Cyproheptadine—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.000492	0.00664	CcSEcCtD
Cyproheptadine—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.000488	0.00659	CcSEcCtD
Cyproheptadine—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.000484	0.00653	CcSEcCtD
Cyproheptadine—CHRM1—trachea—chronic obstructive pulmonary disease	0.000469	0.033	CbGeAlD
Cyproheptadine—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000467	0.0063	CcSEcCtD
Cyproheptadine—Sweating increased—Salbutamol—chronic obstructive pulmonary disease	0.000465	0.00627	CcSEcCtD
Cyproheptadine—CHRM3—smooth muscle tissue—chronic obstructive pulmonary disease	0.000457	0.0322	CbGeAlD
Cyproheptadine—Tension—Aminophylline—chronic obstructive pulmonary disease	0.000454	0.00613	CcSEcCtD
Cyproheptadine—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00045	0.00607	CcSEcCtD
Cyproheptadine—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.000449	0.00606	CcSEcCtD
Cyproheptadine—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.000441	0.00596	CcSEcCtD
Cyproheptadine—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.000434	0.00585	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Montelukast—chronic obstructive pulmonary disease	0.000433	0.00584	CcSEcCtD
Cyproheptadine—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.00043	0.00581	CcSEcCtD
Cyproheptadine—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.000426	0.00574	CcSEcCtD
Cyproheptadine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.000425	0.00574	CcSEcCtD
Cyproheptadine—Neuritis—Prednisone—chronic obstructive pulmonary disease	0.000425	0.00573	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Salbutamol—chronic obstructive pulmonary disease	0.000417	0.00563	CcSEcCtD
Cyproheptadine—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.000415	0.0056	CcSEcCtD
Cyproheptadine—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.000411	0.00555	CcSEcCtD
Cyproheptadine—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000409	0.00552	CcSEcCtD
Cyproheptadine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000406	0.00548	CcSEcCtD
Cyproheptadine—HRH1—respiratory system—chronic obstructive pulmonary disease	0.000404	0.0284	CbGeAlD
Cyproheptadine—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000401	0.00541	CcSEcCtD
Cyproheptadine—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.000396	0.00535	CcSEcCtD
Cyproheptadine—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.000394	0.00532	CcSEcCtD
Cyproheptadine—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.000391	0.00528	CcSEcCtD
Cyproheptadine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000388	0.00523	CcSEcCtD
Cyproheptadine—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000386	0.0052	CcSEcCtD
Cyproheptadine—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.000384	0.00518	CcSEcCtD
Cyproheptadine—Euphoric mood—Prednisolone—chronic obstructive pulmonary disease	0.000375	0.00506	CcSEcCtD
Cyproheptadine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000375	0.00505	CcSEcCtD
Cyproheptadine—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000372	0.00501	CcSEcCtD
Cyproheptadine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000369	0.00497	CcSEcCtD
Cyproheptadine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00036	0.00486	CcSEcCtD
Cyproheptadine—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00036	0.00486	CcSEcCtD
Cyproheptadine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000357	0.00482	CcSEcCtD
Cyproheptadine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000357	0.00481	CcSEcCtD
Cyproheptadine—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.000356	0.00481	CcSEcCtD
Cyproheptadine—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000356	0.00481	CcSEcCtD
Cyproheptadine—HRH1—connective tissue—chronic obstructive pulmonary disease	0.000355	0.025	CbGeAlD
Cyproheptadine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000355	0.00479	CcSEcCtD
Cyproheptadine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000353	0.00476	CcSEcCtD
Cyproheptadine—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00035	0.00473	CcSEcCtD
Cyproheptadine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000348	0.00469	CcSEcCtD
Cyproheptadine—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000346	0.00466	CcSEcCtD
Cyproheptadine—Tension—Formoterol—chronic obstructive pulmonary disease	0.000346	0.00466	CcSEcCtD
Cyproheptadine—Chills—Salbutamol—chronic obstructive pulmonary disease	0.000343	0.00462	CcSEcCtD
Cyproheptadine—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000342	0.00462	CcSEcCtD
Cyproheptadine—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000342	0.00462	CcSEcCtD
Cyproheptadine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000342	0.00461	CcSEcCtD
Cyproheptadine—Protriptyline—SLC6A4—chronic obstructive pulmonary disease	0.000341	0.0981	CrCbGaD
Cyproheptadine—Increased appetite—Prednisolone—chronic obstructive pulmonary disease	0.000337	0.00455	CcSEcCtD
Cyproheptadine—HTR2A—respiratory system—chronic obstructive pulmonary disease	0.000337	0.0237	CbGeAlD
Cyproheptadine—CHRM1—lung—chronic obstructive pulmonary disease	0.000337	0.0237	CbGeAlD
Cyproheptadine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000336	0.00454	CcSEcCtD
Cyproheptadine—HTR2B—lung—chronic obstructive pulmonary disease	0.000335	0.0236	CbGeAlD
Cyproheptadine—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000332	0.00449	CcSEcCtD
Cyproheptadine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00033	0.00445	CcSEcCtD
Cyproheptadine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00033	0.00445	CcSEcCtD
Cyproheptadine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000328	0.00443	CcSEcCtD
Cyproheptadine—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000326	0.0044	CcSEcCtD
Cyproheptadine—HRH1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000325	0.0229	CbGeAlD
Cyproheptadine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000324	0.00437	CcSEcCtD
Cyproheptadine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000324	0.00437	CcSEcCtD
Cyproheptadine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000323	0.00436	CcSEcCtD
Cyproheptadine—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000323	0.00436	CcSEcCtD
Cyproheptadine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000322	0.00435	CcSEcCtD
Cyproheptadine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00032	0.00432	CcSEcCtD
Cyproheptadine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000317	0.00428	CcSEcCtD
Cyproheptadine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000314	0.00423	CcSEcCtD
Cyproheptadine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000312	0.0042	CcSEcCtD
Cyproheptadine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000311	0.0042	CcSEcCtD
Cyproheptadine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000311	0.0042	CcSEcCtD
Cyproheptadine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000306	0.00412	CcSEcCtD
Cyproheptadine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000305	0.00411	CcSEcCtD
Cyproheptadine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000305	0.00411	CcSEcCtD
Cyproheptadine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.0003	0.00405	CcSEcCtD
Cyproheptadine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000299	0.00403	CcSEcCtD
Cyproheptadine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000299	0.00403	CcSEcCtD
Cyproheptadine—HRH1—trachea—chronic obstructive pulmonary disease	0.000298	0.021	CbGeAlD
Cyproheptadine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000298	0.00402	CcSEcCtD
Cyproheptadine—SLC6A2—lung—chronic obstructive pulmonary disease	0.000298	0.021	CbGeAlD
Cyproheptadine—HTR2A—connective tissue—chronic obstructive pulmonary disease	0.000297	0.0209	CbGeAlD
Cyproheptadine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000294	0.00397	CcSEcCtD
Cyproheptadine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000292	0.00394	CcSEcCtD
Cyproheptadine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000287	0.00388	CcSEcCtD
Cyproheptadine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000287	0.00388	CcSEcCtD
Cyproheptadine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000283	0.00382	CcSEcCtD
Cyproheptadine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000282	0.0038	CcSEcCtD
Cyproheptadine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000281	0.00379	CcSEcCtD
Cyproheptadine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000281	0.00379	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000276	0.00372	CcSEcCtD
Cyproheptadine—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000272	0.00368	CcSEcCtD
Cyproheptadine—HTR2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000271	0.0191	CbGeAlD
Cyproheptadine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000271	0.00366	CcSEcCtD
Cyproheptadine—DRD2—lung—chronic obstructive pulmonary disease	0.000271	0.0191	CbGeAlD
Cyproheptadine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000269	0.00362	CcSEcCtD
Cyproheptadine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000269	0.00362	CcSEcCtD
Cyproheptadine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000267	0.0036	CcSEcCtD
Cyproheptadine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000267	0.0036	CcSEcCtD
Cyproheptadine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000265	0.00357	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000262	0.00354	CcSEcCtD
Cyproheptadine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00026	0.00351	CcSEcCtD
Cyproheptadine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00026	0.00351	CcSEcCtD
Cyproheptadine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000259	0.00349	CcSEcCtD
Cyproheptadine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000258	0.00349	CcSEcCtD
Cyproheptadine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000256	0.00345	CcSEcCtD
Cyproheptadine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000256	0.00345	CcSEcCtD
Cyproheptadine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000255	0.00344	CcSEcCtD
Cyproheptadine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000254	0.00342	CcSEcCtD
Cyproheptadine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000253	0.00341	CcSEcCtD
Cyproheptadine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000253	0.00341	CcSEcCtD
Cyproheptadine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000253	0.00341	CcSEcCtD
Cyproheptadine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00025	0.00338	CcSEcCtD
Cyproheptadine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00025	0.00337	CcSEcCtD
Cyproheptadine—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000249	0.00336	CcSEcCtD
Cyproheptadine—HTR2A—trachea—chronic obstructive pulmonary disease	0.000249	0.0175	CbGeAlD
Cyproheptadine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000248	0.00334	CcSEcCtD
Cyproheptadine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000248	0.00334	CcSEcCtD
Cyproheptadine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000248	0.00334	CcSEcCtD
Cyproheptadine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000246	0.00332	CcSEcCtD
Cyproheptadine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000246	0.00332	CcSEcCtD
Cyproheptadine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000245	0.00331	CcSEcCtD
Cyproheptadine—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000245	0.00331	CcSEcCtD
Cyproheptadine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000244	0.00329	CcSEcCtD
Cyproheptadine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000243	0.00328	CcSEcCtD
Cyproheptadine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000241	0.00326	CcSEcCtD
Cyproheptadine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00024	0.00324	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000239	0.00323	CcSEcCtD
Cyproheptadine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000239	0.00322	CcSEcCtD
Cyproheptadine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000238	0.00321	CcSEcCtD
Cyproheptadine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000238	0.00321	CcSEcCtD
Cyproheptadine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000237	0.0032	CcSEcCtD
Cyproheptadine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000237	0.0032	CcSEcCtD
Cyproheptadine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000237	0.00319	CcSEcCtD
Cyproheptadine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000236	0.00318	CcSEcCtD
Cyproheptadine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000236	0.00318	CcSEcCtD
Cyproheptadine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000234	0.00316	CcSEcCtD
Cyproheptadine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000232	0.00313	CcSEcCtD
Cyproheptadine—Cyclobenzaprine—CYP1A2—chronic obstructive pulmonary disease	0.000232	0.0667	CrCbGaD
Cyproheptadine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000228	0.00308	CcSEcCtD
Cyproheptadine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000228	0.00308	CcSEcCtD
Cyproheptadine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000226	0.00306	CcSEcCtD
Cyproheptadine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000225	0.00303	CcSEcCtD
Cyproheptadine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000224	0.00303	CcSEcCtD
Cyproheptadine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000224	0.00303	CcSEcCtD
Cyproheptadine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000224	0.00302	CcSEcCtD
Cyproheptadine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000224	0.00302	CcSEcCtD
Cyproheptadine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000223	0.00301	CcSEcCtD
Cyproheptadine—Irritability—Prednisone—chronic obstructive pulmonary disease	0.00022	0.00296	CcSEcCtD
Cyproheptadine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000216	0.00291	CcSEcCtD
Cyproheptadine—HRH1—lung—chronic obstructive pulmonary disease	0.000214	0.0151	CbGeAlD
Cyproheptadine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000212	0.00285	CcSEcCtD
Cyproheptadine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000206	0.00278	CcSEcCtD
Cyproheptadine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000206	0.00278	CcSEcCtD
Cyproheptadine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000202	0.00273	CcSEcCtD
Cyproheptadine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000197	0.00265	CcSEcCtD
Cyproheptadine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000197	0.00265	CcSEcCtD
Cyproheptadine—Cyclobenzaprine—HTR2A—chronic obstructive pulmonary disease	0.000196	0.0563	CrCbGaD
Cyproheptadine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.00263	CcSEcCtD
Cyproheptadine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000194	0.00261	CcSEcCtD
Cyproheptadine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000193	0.0026	CcSEcCtD
Cyproheptadine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00019	0.00256	CcSEcCtD
Cyproheptadine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00019	0.00256	CcSEcCtD
Cyproheptadine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000186	0.00251	CcSEcCtD
Cyproheptadine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000186	0.00251	CcSEcCtD
Cyproheptadine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000183	0.00247	CcSEcCtD
Cyproheptadine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000183	0.00247	CcSEcCtD
Cyproheptadine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000181	0.00245	CcSEcCtD
Cyproheptadine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000181	0.00245	CcSEcCtD
Cyproheptadine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000181	0.00244	CcSEcCtD
Cyproheptadine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000181	0.00244	CcSEcCtD
Cyproheptadine—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000181	0.00244	CcSEcCtD
Cyproheptadine—Headache—Formoterol—chronic obstructive pulmonary disease	0.00018	0.00243	CcSEcCtD
Cyproheptadine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00018	0.00243	CcSEcCtD
Cyproheptadine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.00018	0.00243	CcSEcCtD
Cyproheptadine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000179	0.00242	CcSEcCtD
Cyproheptadine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000179	0.00242	CcSEcCtD
Cyproheptadine—HTR2A—lung—chronic obstructive pulmonary disease	0.000179	0.0126	CbGeAlD
Cyproheptadine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000178	0.0024	CcSEcCtD
Cyproheptadine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000177	0.00239	CcSEcCtD
Cyproheptadine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000176	0.00238	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000174	0.00235	CcSEcCtD
Cyproheptadine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000173	0.00233	CcSEcCtD
Cyproheptadine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000171	0.00231	CcSEcCtD
Cyproheptadine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000171	0.00231	CcSEcCtD
Cyproheptadine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000171	0.00231	CcSEcCtD
Cyproheptadine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000171	0.00231	CcSEcCtD
Cyproheptadine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000171	0.0023	CcSEcCtD
Cyproheptadine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000171	0.0023	CcSEcCtD
Cyproheptadine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00017	0.00229	CcSEcCtD
Cyproheptadine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000168	0.00226	CcSEcCtD
Cyproheptadine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000167	0.00226	CcSEcCtD
Cyproheptadine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000165	0.00223	CcSEcCtD
Cyproheptadine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.00218	CcSEcCtD
Cyproheptadine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000158	0.00214	CcSEcCtD
Cyproheptadine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000156	0.0021	CcSEcCtD
Cyproheptadine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000153	0.00207	CcSEcCtD
Cyproheptadine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000152	0.00205	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000151	0.00203	CcSEcCtD
Cyproheptadine—Mianserin—SLC6A4—chronic obstructive pulmonary disease	0.000146	0.042	CrCbGaD
Cyproheptadine—Carbamazepine—CYP1A2—chronic obstructive pulmonary disease	0.000144	0.0416	CrCbGaD
Cyproheptadine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000141	0.0019	CcSEcCtD
Cyproheptadine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00014	0.00189	CcSEcCtD
Cyproheptadine—Mianserin—CYP1A2—chronic obstructive pulmonary disease	0.000133	0.0383	CrCbGaD
Cyproheptadine—Nortriptyline—SLC6A4—chronic obstructive pulmonary disease	0.000131	0.0376	CrCbGaD
Cyproheptadine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000131	0.00176	CcSEcCtD
Cyproheptadine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000128	0.00173	CcSEcCtD
Cyproheptadine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000127	0.00172	CcSEcCtD
Cyproheptadine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000125	0.00168	CcSEcCtD
Cyproheptadine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000124	0.00168	CcSEcCtD
Cyproheptadine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000124	0.00167	CcSEcCtD
Cyproheptadine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000122	0.00164	CcSEcCtD
Cyproheptadine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.00012	0.00162	CcSEcCtD
Cyproheptadine—Nortriptyline—CYP1A2—chronic obstructive pulmonary disease	0.000119	0.0342	CrCbGaD
Cyproheptadine—Loxapine—SLC6A4—chronic obstructive pulmonary disease	0.000116	0.0334	CrCbGaD
Cyproheptadine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000113	0.00153	CcSEcCtD
Cyproheptadine—Mianserin—HTR2A—chronic obstructive pulmonary disease	0.000112	0.0323	CrCbGaD
Cyproheptadine—Shock—Prednisone—chronic obstructive pulmonary disease	0.000111	0.0015	CcSEcCtD
Cyproheptadine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.00011	0.00149	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000109	0.00148	CcSEcCtD
Cyproheptadine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000108	0.00145	CcSEcCtD
Cyproheptadine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.00139	CcSEcCtD
Cyproheptadine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000102	0.00138	CcSEcCtD
Cyproheptadine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000102	0.00137	CcSEcCtD
Cyproheptadine—Nortriptyline—HTR2A—chronic obstructive pulmonary disease	0.0001	0.0289	CrCbGaD
Cyproheptadine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	9.96e-05	0.00134	CcSEcCtD
Cyproheptadine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	9.83e-05	0.00133	CcSEcCtD
Cyproheptadine—Rash—Prednisolone—chronic obstructive pulmonary disease	9.82e-05	0.00132	CcSEcCtD
Cyproheptadine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	9.81e-05	0.00132	CcSEcCtD
Cyproheptadine—Fatigue—Prednisone—chronic obstructive pulmonary disease	9.75e-05	0.00132	CcSEcCtD
Cyproheptadine—Headache—Prednisolone—chronic obstructive pulmonary disease	9.75e-05	0.00132	CcSEcCtD
Cyproheptadine—Constipation—Prednisone—chronic obstructive pulmonary disease	9.67e-05	0.00131	CcSEcCtD
Cyproheptadine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	9.32e-05	0.00126	CcSEcCtD
Cyproheptadine—Nausea—Prednisolone—chronic obstructive pulmonary disease	9.25e-05	0.00125	CcSEcCtD
Cyproheptadine—Clozapine—CYP1A1—chronic obstructive pulmonary disease	9.21e-05	0.0265	CrCbGaD
Cyproheptadine—Amitriptyline—SLC6A4—chronic obstructive pulmonary disease	9.07e-05	0.0261	CrCbGaD
Cyproheptadine—Urticaria—Prednisone—chronic obstructive pulmonary disease	8.99e-05	0.00121	CcSEcCtD
Cyproheptadine—Loxapine—HTR2A—chronic obstructive pulmonary disease	8.92e-05	0.0257	CrCbGaD
Cyproheptadine—Clozapine—CYP1A2—chronic obstructive pulmonary disease	8.88e-05	0.0255	CrCbGaD
Cyproheptadine—Amitriptyline—CYP1A2—chronic obstructive pulmonary disease	8.26e-05	0.0237	CrCbGaD
Cyproheptadine—Asthenia—Prednisone—chronic obstructive pulmonary disease	8.12e-05	0.0011	CcSEcCtD
Cyproheptadine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	7.74e-05	0.00104	CcSEcCtD
Cyproheptadine—Clozapine—HTR2A—chronic obstructive pulmonary disease	7.49e-05	0.0216	CrCbGaD
Cyproheptadine—Dizziness—Prednisone—chronic obstructive pulmonary disease	7.48e-05	0.00101	CcSEcCtD
Cyproheptadine—Vomiting—Prednisone—chronic obstructive pulmonary disease	7.19e-05	0.00097	CcSEcCtD
Cyproheptadine—Rash—Prednisone—chronic obstructive pulmonary disease	7.13e-05	0.000962	CcSEcCtD
Cyproheptadine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	7.13e-05	0.000961	CcSEcCtD
Cyproheptadine—Headache—Prednisone—chronic obstructive pulmonary disease	7.09e-05	0.000956	CcSEcCtD
Cyproheptadine—Amitriptyline—HTR2A—chronic obstructive pulmonary disease	6.97e-05	0.02	CrCbGaD
Cyproheptadine—Nortriptyline—ALB—chronic obstructive pulmonary disease	6.87e-05	0.0198	CrCbGaD
Cyproheptadine—Nausea—Prednisone—chronic obstructive pulmonary disease	6.72e-05	0.000907	CcSEcCtD
Cyproheptadine—Amitriptyline—ALB—chronic obstructive pulmonary disease	4.77e-05	0.0137	CrCbGaD
Cyproheptadine—CHRM1—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	1.35e-05	0.000384	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.35e-05	0.000384	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.34e-05	0.000383	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.34e-05	0.000383	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.34e-05	0.000383	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.34e-05	0.000381	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.34e-05	0.00038	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.33e-05	0.000379	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.32e-05	0.000377	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—GCLC—chronic obstructive pulmonary disease	1.31e-05	0.000374	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.31e-05	0.000373	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.31e-05	0.000373	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.29e-05	0.000367	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.29e-05	0.000367	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.29e-05	0.000366	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.29e-05	0.000366	CbGpPWpGaD
Cyproheptadine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.28e-05	0.000365	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.28e-05	0.000365	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.28e-05	0.000365	CbGpPWpGaD
Cyproheptadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.28e-05	0.000365	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.28e-05	0.000364	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.28e-05	0.000364	CbGpPWpGaD
Cyproheptadine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.28e-05	0.000363	CbGpPWpGaD
Cyproheptadine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.27e-05	0.000362	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.27e-05	0.00036	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.26e-05	0.00036	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.26e-05	0.00036	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.25e-05	0.000356	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.24e-05	0.000354	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.24e-05	0.000353	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.23e-05	0.000351	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.22e-05	0.000348	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.22e-05	0.000348	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.22e-05	0.000346	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.21e-05	0.000345	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.2e-05	0.000342	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—CTGF—chronic obstructive pulmonary disease	1.2e-05	0.000341	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.2e-05	0.000341	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.18e-05	0.000335	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.17e-05	0.000334	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.17e-05	0.000333	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.16e-05	0.000329	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.15e-05	0.000329	CbGpPWpGaD
Cyproheptadine—HTR6—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.14e-05	0.000324	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.13e-05	0.000322	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.1e-05	0.000315	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—ALB—chronic obstructive pulmonary disease	1.09e-05	0.000311	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.09e-05	0.000311	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.09e-05	0.00031	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.08e-05	0.000309	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.07e-05	0.000304	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.06e-05	0.000303	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.06e-05	0.000302	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.05e-05	0.000299	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—NOS3—chronic obstructive pulmonary disease	1.04e-05	0.000298	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.04e-05	0.000296	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.03e-05	0.000294	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.03e-05	0.000294	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.03e-05	0.000292	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.01e-05	0.000289	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.01e-05	0.000287	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.88e-06	0.000281	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.58e-06	0.000273	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.43e-06	0.000269	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.42e-06	0.000268	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.4e-06	0.000268	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.37e-06	0.000267	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.37e-06	0.000267	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.36e-06	0.000266	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.34e-06	0.000266	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.31e-06	0.000265	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.25e-06	0.000263	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.21e-06	0.000262	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.19e-06	0.000262	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.09e-06	0.000259	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.02e-06	0.000257	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.9e-06	0.000254	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.76e-06	0.000249	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.74e-06	0.000249	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.71e-06	0.000248	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.68e-06	0.000247	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.6e-06	0.000245	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.47e-06	0.000241	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.42e-06	0.00024	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.39e-06	0.000239	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.38e-06	0.000239	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.36e-06	0.000238	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.32e-06	0.000237	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.22e-06	0.000234	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.08e-06	0.00023	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.07e-06	0.00023	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.04e-06	0.000229	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.03e-06	0.000229	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.01e-06	0.000228	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	7.94e-06	0.000226	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.65e-06	0.000218	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.61e-06	0.000217	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.6e-06	0.000216	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.56e-06	0.000215	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.55e-06	0.000215	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.4e-06	0.000211	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.34e-06	0.000209	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.31e-06	0.000208	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.28e-06	0.000207	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.28e-06	0.000207	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.26e-06	0.000207	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.24e-06	0.000206	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.22e-06	0.000206	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.22e-06	0.000206	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.21e-06	0.000205	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.21e-06	0.000205	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.18e-06	0.000205	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.16e-06	0.000204	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.15e-06	0.000204	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.09e-06	0.000202	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.89e-06	0.000196	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.88e-06	0.000196	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.8e-06	0.000194	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.77e-06	0.000193	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.72e-06	0.000191	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.67e-06	0.00019	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.61e-06	0.000188	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.59e-06	0.000188	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.58e-06	0.000187	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.57e-06	0.000187	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.57e-06	0.000187	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.55e-06	0.000187	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.55e-06	0.000187	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.53e-06	0.000186	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.51e-06	0.000185	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.49e-06	0.000185	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.45e-06	0.000184	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.42e-06	0.000183	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.31e-06	0.00018	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.29e-06	0.000179	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.28e-06	0.000179	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.27e-06	0.000178	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.2e-06	0.000177	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.1e-06	0.000174	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.97e-06	0.00017	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.87e-06	0.000167	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.86e-06	0.000167	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.84e-06	0.000166	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.82e-06	0.000166	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.81e-06	0.000165	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.77e-06	0.000164	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.59e-06	0.000159	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.57e-06	0.000159	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.56e-06	0.000158	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.52e-06	0.000157	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—ALB—chronic obstructive pulmonary disease	5.46e-06	0.000155	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.34e-06	0.000152	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.31e-06	0.000151	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.3e-06	0.000151	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—NOS3—chronic obstructive pulmonary disease	5.22e-06	0.000149	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.09e-06	0.000145	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.07e-06	0.000144	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.04e-06	0.000144	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.96e-06	0.000141	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.91e-06	0.00014	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.83e-06	0.000138	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.82e-06	0.000137	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.8e-06	0.000137	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.79e-06	0.000136	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.74e-06	0.000135	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.69e-06	0.000133	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.61e-06	0.000131	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.6e-06	0.000131	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.59e-06	0.000131	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.57e-06	0.00013	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.55e-06	0.00013	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.53e-06	0.000129	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.53e-06	0.000129	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.52e-06	0.000129	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.5e-06	0.000128	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.47e-06	0.000127	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.46e-06	0.000127	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.4e-06	0.000125	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.39e-06	0.000125	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.38e-06	0.000125	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.36e-06	0.000124	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.32e-06	0.000123	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.3e-06	0.000122	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.28e-06	0.000122	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.15e-06	0.000118	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.09e-06	0.000116	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.07e-06	0.000116	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.07e-06	0.000116	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.97e-06	0.000113	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.9e-06	0.000111	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.9e-06	0.000111	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.88e-06	0.000111	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.87e-06	0.00011	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.83e-06	0.000109	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.77e-06	0.000107	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.75e-06	0.000107	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.71e-06	0.000106	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.7e-06	0.000106	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.69e-06	0.000105	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.68e-06	0.000105	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.67e-06	0.000105	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.65e-06	0.000104	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.64e-06	0.000104	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.59e-06	0.000102	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.53e-06	0.000101	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.52e-06	0.0001	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.51e-06	0.0001	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.5e-06	9.97e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.47e-06	9.87e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.43e-06	9.77e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.42e-06	9.74e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.37e-06	9.59e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.35e-06	9.55e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.3e-06	9.41e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.29e-06	9.36e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.22e-06	9.18e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.17e-06	9.03e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.16e-06	9.01e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.15e-06	8.98e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.14e-06	8.95e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.13e-06	8.92e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.11e-06	8.87e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.96e-06	8.42e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.91e-06	8.29e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.9e-06	8.27e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.9e-06	8.26e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.89e-06	8.24e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.89e-06	8.22e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.86e-06	8.14e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.85e-06	8.13e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.85e-06	8.11e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.84e-06	8.08e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.83e-06	8.06e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.8e-06	7.98e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.77e-06	7.9e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.76e-06	7.86e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.54e-06	7.23e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.53e-06	7.19e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.43e-06	6.94e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.4e-06	6.82e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.39e-06	6.81e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.38e-06	6.79e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.38e-06	6.77e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.35e-06	6.7e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.23e-06	6.35e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.19e-06	6.25e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.19e-06	6.23e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.18e-06	6.21e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.17e-06	6.19e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.15e-06	6.13e-05	CbGpPWpGaD
